{{Rsnum
|rsid=565186
|Chromosome=11
|Orientation=plus
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene=PGR
|position=101112898
|Gene_s=PGR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 5.3 | 29.2 | 65.5
| HCB | 0.0 | 2.2 | 97.8
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.7 | 99.3
| ASW | 0.0 | 3.5 | 96.5
| CHB | 0.0 | 2.2 | 97.8
| CHD | 0.0 | 1.8 | 98.2
| GIH | 0.0 | 13.9 | 86.1
| LWK | 0.0 | 0.9 | 99.1
| MEX | 3.5 | 28.1 | 68.4
| MKK | 0.0 | 7.7 | 92.3
| TSI | 3.9 | 30.4 | 65.7
| HapMapRevision=28
}}Part of a haplotype [[Gs286]], standalone effect for [[endometrial cancer]] is ambiguous. Tightly linked with [[PROGINS]] [[allele]].

{{PMID Auto GWAS
|PMID=20547493
|Trait=Endometrial cancer
|Title=Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.
|RiskAllele=C
|Pval=0.43
|OR=1.22
|ORtxt=[1.00-1.50]
|OA=1
}}

{{PMID|15632380}} Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}